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Human exposure to carcinogenic Cr(VI) compounds is found among workers in a large number of
professional groups, and it can also occur through environmental pollution. A significant number of
toxic waste sites contain Cr as a major contaminant. In this paper we summarize our efforts to
apply measurements of DNA-protein cross-links (DPC) as a test for biologically active doses of
Cr(VI). DPC were found at elevated levels in lymphocytes in several human populations with low to
medium Cr exposures. At high exposure to Cr(VI), exemplified by a group of Bulgarian chrome-
platers, DPC plateaued and adducts' levels were similar to those found in environmentally exposed
individuals. Lymphocytic DPC correlated strongly with Cr levels in erythrocytes that are indicative
of Cr(VI) exposure. DPC in lymphocytes were not confounded by such variables as smoking, age,
body weight, gender, or ethnicity. A new version of the cross-link assay offers improved sensitivity
and requires a small amount of biologic material. Preliminary results indicate that the ability of DPC
to reach detectable levels at low levels of Cr exposure could be related to a lack of repair of these
lesions in lymphoid cells. Cr(lll)-mediated cross-links of DNA with peptide glutathione or single
amino acids were mutagenic in human cells, with a relationship of higher molecular weight of the
peptide/amino acid correlating with a more potent mutagenic response. We speculate that bulky
DPC could also have a significant promutagenic effect. The current methodology does not allow
specific determination of Cr-induced DPC; however, demonstrated sensitivity of DPC
measurements and the assay's large sample capacity may allow this assay to be used as the initial
screening test for the occurrence of DNA damage in Cr(V1)-exposed populations. Environ Health
Perspect 106(Suppl 4):969-974 (1998). http://ehpnetl.niehs.nih.gov/docs/1998/Suppl-4/
969-974zhitkovich/abstract.html
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Introduction
Epidemiologic studies have consistently
shown that human exposure to hexavalent
Cr compounds (chromates) is associated
with a higher incidence ofrespiratory can-
cers (1,2). Cr(VI) compounds are potent
carcinogens in animals, as well as mutagens
in bacterial and mammalian cell-based
mutagenicity assays (3-5). Cr(VI) readily
enters all types ofcells through a general
anion channel, leading to a significant intra-
cellular accumulation ofthis metal (6,7).
Chromate is isostructural with phosphate
and sulfate anions, which is the basis for its
rapid transport into cells and penetration
into many tissues. Intracellularly, Cr(VI)
undergoes reductive metabolism, ulti-
mately forming Cr(III) (8,9). Because of
extremely tight binding ofCr(III) by intra-
cellular macromolecules, a significant por-
tion ofCr(III) becomes trapped inside the
cell for long periods of time (10). Several
radical species, as well as Cr(V) and
Cr(IV), have been detected during the
reduction of Cr(VI) in vitro (11-14).
Although numerous cellular constituents
were capable of reducing Cr(VI) in vitro,
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in vivo reduction ofCr(VI) is believed to
be driven by ascorbate and nonprotein
thiols such as glutathione and cysteine
(8,15,16). Formation of Cr(III) in cells
leads to the induction ofstable ternary
DNA adducts that include proteins, glu-
tathione, or selected amino acids cross-
linked to DNA by Cr(III) (17-19).
According to recent estimates, more
than 300,000 U.S. workers are potentially
exposed to Cr and Cr-containing com-
pounds in the workplace (20). Workers
among approximately 80 professional
groups can experience Cr exposure. The
highest levels ofoccupational exposure to
Cr and its compounds are typically found
among stainless-steel welders, chrome-
platers, and chromate-production workers
(1,2,20). Environmental contamination
with Cr is also widespread and has a poten-
tial to affect large groups ofthe general
population. Major anthropogenic sources
ofatmospheric Cr contamination in the
United States are oil and coal combustion,
steel production, chemical manufacture,
primary metal production, chrome plating,
and cooling towers (20). Cr release by the
electroplating, leather tanning, and textile
industries is largely responsible for water
contamination. Disposal ofCr-containing
waste products and coal ash from electrical
utilities and other industries are the major
sources of Cr release into the soil (1,20).
Cr-containing slag produced during chro-
mate manufacturing processes was some-
times improperly disposed of in landfill
sites. For example, there have been reports
indicating human exposure to Cr in
Hudson County, New Jersey, where mil-
lions oftons ofCr-containing mine tailings
have been used as landfill and in commer-
cial and residential construction (21-23).
Cr is a major contaminant at more than
40% of the toxic sites designated as
Superfund sites by the U.S. Environmental
Protection Agency (20). This number may
in fact be even greater because not all
Superfund sites were analyzed for possible
Cr contamination.
Current biomonitoring approaches for
assessing occupational exposure to Cr com-
pounds are typically based on measure-
ments of Cr in urine or serum. Elevated
levels ofCr in these biologic fluids are well
documented in workers employed in indus-
tries with high levels ofexposure (24-26).
Although urinary Cr screening can some-
times reveal environmental exposures (21),
these measurements can be significantly
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influenced by dietary factors, which are dif-
ficult to account for. Acontribution ofdiet-
originated nontoxic Cr(III) to serum and
urine Cr levels can be significant (27,28),
leading to difficulties in assessing low-level
exposures to toxic Cr(VI). Dietary Cr is
also likely to lead to high temporal variabil-
ity in Cr measurements. Based on the fact
that soluble inorganic Cr(III) compounds
enter cells poorly, monitoring ofCr levels
in erythrocytes was suggested to preferen-
tially assess toxic Cr(VI) exposures (10).
However, Cr(III) compounds with organic
ligands can cross cell membranes, although
less readily than carcinogenic Cr(VI) (29).
Measurements ofCr content ofbiologic tis-
sues is not a trivial task even when expen-
sive instrumentation is available, as
contamination problems are ubiquitous.
Introduction of appropriate background
correction techniques in the 1980s and an
understanding of contamination sources
have led to a reliable determination ofCr in
biologic fluids by many laboratories; how-
ever, Cr measurements can still be variable
and profoundly influenced by sample
collection andlaboratory procedures.
Estimation ofa biologically active dose
ofCr(VI) based on chromosomal damage
end points even in highlyexposed industrial
workers has not been successful (30-33),
perhaps because offrequent concomitant
exposures to other clastogens (i.e., Ni in
welders) as well as strong confounding
effects ofcigarette smoking.
In an attempt to develop a biologic
dosimeter for Cr(VI) exposures that would
not be influenced by dietary Cr and would
reflect damage to a biologically relevant
target DNA, investigators have applied
measurements ofDNA-protein cross-links
(DPC) in peripheral blood mononuclear
cells ofhuman subjects as a biomonitoring
tool. This paper will summarize our find-
ings in human studies and present prelimi-
nary data on biologic characteristics of
Cr(VI)-induced DPC.
DNA-Protein
Cross-Link Assay
In the past, DPC typically have been
measured using an alkaline elution method.
Although the alkaline elution assay is quite
sensitive, its application to biomonitoring
studies was seriously hampered by the need
for freshly prepared cell lysates and by the
assay's limited sample capacity. We have
developed a new, simple, and sensitive assay
for measurements ofDPC, which has been
validated using various cross-linking agents
in cultured cells as well as in chromate-
exposed animals (34). This new assay is
more sensitive in the detection of Cr(VI)-
induced DPC in experimental animals than
the previously used alkaline elution method
(35). The principle ofthe assay is based on
the selective precipitation of proteins and
protein-linked DNA in the presence of
sodium dodecyl sulfate (SDS) and K+.
Percentage oftotal cellular DNA precip-
itable by K-SDS is a measure of DPC.
DNA was quantitated with the fluorescent
dye Hoechst 33258 (Sigma Chemical Co.,
St. Louis, MO) and with this dye a mini-
mal amount of 1 million cells per sample
was required to detect cross-linked DNA.
We found that the DPC remained stable
when SDS-lysed cell samples were kept
frozen. This allowed us to store samples and
use internal standards to correct for differ-
ences in the determination ofDPC in sepa-
rate assay runs (batch effect). The minimal
sample size needed to detect a statistically
significant increase in DPC without the
use of internal controls was calculated to
be seven controls and seven exposed indi-
viduals (36). The detection limit for DPC
was estimated to be about 1 adduct per
1-2 x 107 bases. Two independent studies
devoted to the technical aspects of the K-
SDS DNA-protein cross-linking assay
demonstrated its high reproducibility in
different laboratories (37,38). The most
important factor in the reproducible
measurements of DPC by this assay was
effective shearing ofSDS-lysed cell samples
(37). Although the K-SDS assay cannot be
considered specific for Cr-induced DPC,
we were able to eliminate many aldehyde-
induced cross-links by heating ofcell lysates
prior to the cross-link analysis (39).
Measurements of
DNA-Protein Cross-Links
in Human Populations
The potential utility ofDPC measurements
in assessment ofhuman exposure to toxic
Cr compounds has been tested in different
groups ofindividuals who were either occu-
pationallyexposed to Cr(VI) orwho lived in
Cr-contaminated areas (summarized in
Table 1). Our first study group included
metal-arc welders (mild-steel welders) expe-
riencing exposure to Cr via inhalation of
welding fumes (40). The data demonstrated
a significant increase in DPC in the total
white blood cells ofwelders as compared to
local controls. It should be noted that mild-
steel welders are considered a relatively low
Cr-exposure group. The increase in DPC in
the welder group might have been more sig-
nificant had we used lymphocytes in place
oftotal white blood cells. Approximately
60% oftotal white blood cell population are
granulocytes that stay in the bloodstream
only for a few days; therefore, these cells
could not experience significant Cr expo-
sure. Significant increases in the number of
lymphocytic DPC among welders were also
reported byother investigators (41,42).
DPC were also measured in lympho-
cytes ofhighly exposed chrome-platers and
two groups of control subjects from
Bulgaria (43). Individual internal doses of
Cr were estimated on the basis ofCr mea-
surements in urine, erythrocytes, and lym-
phocytes. Lymphocytic DPC correlated
strongly with Cr levels in erythrocytes at
low and moderate exposures; however, no
correlation was found with urinary Cr
Table 1. Summary ofDNA-protein cross-link measurements in lymphocytes ofCr-exposed populations.
Crexposure, CR exposure, DNA-protein
Population source level cross-linksa Confounders Reference
Welders Welding fumes Low-medium Increased None Costa et al. (40)
Popp et al. (41)
Werfel et al. (42)
Residents of Hudson County, NewJersey Environmental Low Increased None Taioli et al. (44)
Residents ofJambol, Bulgaria Environmental Low-medium Increased None Zhitkovich et al. (43)
Chrome platers, Jambol, Bulgaria Acidic chromium mists High No increase above
environmentally
exposed controls None Zhitkovich etal. (43)
"All increases in DPC were statistically significant.
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measurements. Urinary Cr levels represent
not only exposure to Cr (VI), but also to
dietary Cr(III), whereas red blood cell Cr
levels are indicators of exposure to toxic
hexavalent Cr. At the highest levels of Cr
exposure, DPC leveled off. The saturation
of lymphocytic DPC was estimated to
occur at 7 to 8 pg/l Cr in erythrocytes. A
number ofcontrol subjects exhibited sig-
nificantly high internal Cr doses apparently
due to environmental exposures, and this
was associated with elevated levels ofDPC.
The use ofDPC measurements in lym-
phocytes for assessment of biologically
effective doses ofCr was additionally tested
in the United States among individuals
experiencing environmental Cr exposure
(44). Hudson County, New Jersey, was a
major center for chromate and bichromate
production for about 70 years (22).
Approximately 2 million tons of Cr-con-
taining slag were generated. The slag was
used as clean fill in a large number ofresi-
dential, commercial, and industrial con-
struction sites. Studies conducted by the
New Jersey Department ofEnvironmental
Protection (Trenton, NJ) and Rutgers
University (Piscataway, NJ) have registered
increases in spot urinary Cr concentrations
and in dust Cr levels in local homes
(21,23). In collaboration with Rutgers
University, we obtained blood from indi-
viduals thought to have Cr exposure based
on elevated urinary and house dust Cr lev-
els. There was a substantially higher level
of DPC among these individuals as com-
pared to control subjects from other areas
ofNewJersey and NewYork that were not
contaminated with Cr (44).
In all human studies DPC values were
not affected byweight, age, race, gender, or
smoking among both control and exposed
populations (40-46).
New Developments
in DNA-Protein
Cross-Link Assay
The sensitivity of the DPC assay was
directly related to the methodology of
DNA determination. The most sensitive
technique of DNA detection involves
hybridization with 32P-labeled DNA
probes. Figure 1 compares the results of
DPC measurements by the standard fluo-
rescent assay and by a slot-blotting proce-
dure using human-specific Alu DNA as a
hybridization probe. Use ofthe hybridiza-
tion technique led to an approximately
4-fold decrease in the background com-
pared to the fluorescence-based method. As
a result, the dose-response curve for
13 -
11 -
0
C.)
0
~0
cS
CL
95
7.-
5.-
* Hoechst 33258
A 32P-labeled A/u DNA
3
0 15 30 45
Chromate,pkM
Figure 1. Induction of DNA-protein crc
chromate as measured by the fluorescent C
tion versions of the K-SDS method. Burkit
cells transformed with Epstein-Barr
exposed for 16 hr to potassium chromate in
media supplemented with 10% serum.
washed with a phosphate buffer, counted,;
0.5% SDS, 20 mM Tris-HCI, pH 7.5. DPC
performed as described earlier byZhitkovicl
Cross-linked DNA was detected eitherwith
cent dye Hoechst 33258 or by slot-blot h
with 32P-labeled A/u DNA. Shown ar
standard errorfrom four independent experi
chromate exhibits substantialbI
sensitivity. The major reason
observed decrease in backgroun
with the use ofthe hybridization n
DNA detection is likely related to
ination ofa nonspecific signal ob
the Hoechst assay because ofthe
ofresidual amounts ofSDS. The,
method enables the quantitation
amounts ofDNA on the filter an
the use ofsubstantially smaller ni
cells for assessing intracellub2
Hybridization detection ofDPC
measurements ofthese adducts in
1000 to 2000 cells, making DPC
in cell targets such as nasal epith
buccal cells. It is possible tha
improved DPC assay had been a
our human studies, the differences
control and exposed populatioi
have been significantly greater.
Mutagenicity of Amino
Acid- and Glutathione-I
Cross-Links
An important consideration in th4
tion of biomarker measuremeni
assessment is understanding the
consequences of a measured en
The role of a biomarker in risk a
might be more significant ifthe biomarker
measures biologic changes that are mecha-
nistically involved in the pathogenesis of
chemical-induced disease. For DNA-based
bioassays, the mechanistic involvement in
the pathogenesis is usually related to the
question of mutagenicity of a particular
DNA modification. To study the mutagenic
potential ofCr(VI)-induced DPC, we tested
mutagenicity ofamino acid-/glutathione-
Cr(III)-DNA adducts using a shuttle vector
4 mutagenicity system (47,48). In addition to
the formation ofDPC, chromate exposure
ofcells also leads to DNA cross-linking of
60 75 tripeptide glutathione and several individual
amino acids (18). Both protein and amino
acid-/glutathione-DNA cross-links induced
)ss-links by by chromate are mediated by Cr(III) and
Dr hybridiza- formed by involvement ofthe same chemi-
llymphoma cal groups (49,50). The pSP189 plasmid
virus were containing sup Fgene as a mutagenic target
RPMI 1640 (47) was treated with Cr(III) or preincu-
Cells were bated Cr(III)-glutathione mixtures, purified
andlysed in from unreacted components and then used
assay was for human cell transfection experiments. h et al. (341. Adducted and control plasmids were trans- the fluores- fected into normal human fibroblasts ybridization
e means + immortalized with SV40 virus (HF/SV cell
iments. line). Two days after transfection the plas-
mid was isolated and treated with DpnI
restrictase to eliminate unreplicated mole-
y greater cules. The DpnI-resistant plasmids were
for the transfected into an indicator bacteria and
Ld values the frequency ofmutant colonies was deter-
nethod of mined (Figure 2). The results show that
the elim- bulky glutathione-Cr(III)-DNA adducts
)served in were strongly mutagenic, whereas small
presence Cr(III)-DNA adducts were only weakly
Alu-based mutagenic. Cr(III)-histidine and Cr(III)-
ofsmall cysteine adducts had intermediate muta-
d permits genic potential. A significant increase in the
umber of mutation frequency was observed at less
ar DPC. than 1 glutathione adduct per 100 base
can allow pairs. Because they are substantially larger
as few as than DNA-glutathione adducts, DPC
possible might have an even greater mutagenic
ielium or potential. Unfortunately, similar studies
it if this with DPC are challenging with the current
pplied in technology. A complete account ofexperi-
s between ments on the mutagenicity ofCr(III)-DNA
ns might adducts is published elsewhere (51).
DNA
e applica-
ts to risk
biologic
id point.
ssessment
Stability of
Chromate-lnduced
DNA-Protein Cross-Links
The ability of the DPC biomarker to
detect low-level human exposures to Cr
could indicate that this type ofDNA dam-
age might not be efficiently repaired.
Unrepaired DPC would then accumulate
in long-lived populations oflymphocytes.
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Figure2. Mutagenicity ofbinaryandternaryCr(lll)-DNA
adducts at the supFlocus of pSP189 shuttle vector after
replication in repair-proficient human fibroblasts. The
pSP189 plasmid was treated with Cr(lil), Cr(lll)-cysteine
(Cys), Cr(lil)-histidine (His), or Cr(li)-glutathione (GSH) to
form binary or ternary Cr(lil)-DNA adducts. The DNA
was purified from unreacted components and trans-
fected into SV-40 transformed human fibroblasts.
Plasmids were recovered 48 hr later, treated with Dpnl,
and electrotransfected into the indicator MBL50 bacte-
ria. Mutation frequency represents a ratio ofthe number
of mutants to the number of transfectants. The number
of Cr adducts formed on the plasmid DNA was deter-
mined by inclusion of radioactive 51Cr in the parallel set
of tubes (51). Shown are means±standard deviation
fromthreetofive independentexperiments.
Human T lymphocytes, which represent
more than 90% oftotal lymphocyte popu-
lation, are estimated to have a life span of
several years (52). Because repair ofchro-
mate-induced DPC has not been well stud-
ied, we attempted to assess persistence of
these adducts in human Burkitt lymphoma
cells transformed with Epstein-Barr virus
(EBV-BL cells). Transformation ofcells
with Epstein-Barr virus leads to the inacti-
vation of apoptotic DNA fragmentation.
Intactness ofthe DNA is essential to the
determination ofDPC by the K-SDS assay,
and the use ofcells with inactivated DNA
fragmentation pathway permits uncompro-
mised analysis ofDPC over long periods of
time. Figure 3 shows results ofDPC mea-
surements in EBV-BL cells exposed to two
concentrations of potassium chromate.
Cells were exposed for 3 hr and DPC were
measured at different time intervals after
chromate removal. Levels ofDPC increased
with time and these adducts do not seem to
be repaired. At 100 pM chromate exposure,
DPC appeared to rise almost linearly with
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Figure 3. Time course of DNA-protein cross-link
formation in human lymphoma cells by potassium
chromate. EBV-BL cells were exposed to 100 pM or
250 pM chromate for 3 hrfollowed by incubation in Cr-
free media for different time intervals. DPC were mea-
sured by the A/u hybridization version of the K-SDS
assay immediately after exposure (0 hr postexposure),
4, 24, and 48 hr after Cr removal. Shown are
means±SE of six measurements.
the duration ofincubation. This dose of
chromate did not induce detectable cyto-
toxicity at any time points studied, as deter-
mined by the trypan blue staining test, and
48 hr after exposure to 100 pM chromate,
cell proliferation was restored. The highest
dose ofchromate did not induce cytotoxic-
ity immediately after exposure, but 48 hr
later only 50% of the cells were viable,
which coincided with a decrease in the lev-
els ofDPC. Relatively weak cytotoxicity of
short-term chromate treatments was also
reported for CHO cells (53,54).
Similar, though not identical, kinetics
ofDPC formation were observedwhen pri-
maryhuman lymphocytes were treated with
chromate (Figure 4). Levels of DPC were
again risingwith time, with the most signif-
icant increases observed between 24 and 48
hr. No cytotoxicity was observed imme-
diately or 3 hr after chromate exposure,
whereas at the 48-hr postincubation point
cell viability was decreased to 60 to 70%.
Although a larger number ofsamples and
lower doses ofCr(VI) will be needed to bet-
ter define the time course of chromate-
induced DPC, the results already obtained
point to an accumulation of DPC with
time. Although these results may appear
unusual based on kinetics ofadduct forma-
tion by organic compounds, Cr-dependent
DNA adduction might be very different.
Once formed inside the cells, Cr(III) is
1 4
36 48
Postexposure time, hr
Figure 4. Time-dependent formation of DNA-protein
cross-links (DPC) in human peripheral blood lympho-
cytes by potassium chromate. Blood was collected by
venipuncture in tubes containing EDTA. Lymphocytes
were isolated by a standard Ficoll/sodium diatrizoate
technique. Purified lymphocytes were exposed to 100
or 250 pM chromate for 3 hr and then incubated in Cr-
free media for different periods of time. DPC were
measured bythe A/uhybridization version ofthe K-SDS
assay. Shown are means±SE ofsix measurements.
slowly excreted, with a substantial portion
ofthis metal essentially trapped intracellu-
larly. The long-term presence of Cr(III)
presents a possibility ofadditional forma-
tion of DPC with time until Cr(III) is
completely inactivated by chelation with
other ligands.
Summary
The application ofthe K-SDS method for
measurements ofDPC in peripheral blood
lymphocytes appeared to provide a suffi-
ciently sensitive approach to determine
DNA damage in populations environmen-
tally or occupationally exposed to Cr. The
ability to detect low levels ofCr exposure
with the use ofDPC seems to be related to
the kinetics of the formation of this
adduct. Experiments with amino acid and
peptide Cr(III)-DNA cross-links suggested
that Cr-induced DPC were likely to be
mutagenic in human cells. The K-SDS
assay is relatively nonspecific with respect
to the chemical nature of DPC; however,
only a limited number of agents induce a
thermostable form ofcross-links and some
of these compounds do not reach the
bloodstream to damage lymphocytic DNA
(exemplified by no elevation ofcross-links
in smokers). The detection ofelevated lev-
els ofDPC in several human populations
with relatively low Cr exposures, as well as
a strong correlation between internal dose
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of Cr and measurable adducts, indicated
that determination ofDPC can be used as
a test for the presence ofDNA damage due
to Cr exposure. Given that the cross-link
assay is inexpensive and permits analysis of
many samples, we envision that DPC mea-
surements could be performed for rapid
DNA-damage screening of potentially
exposed populations, whereas additional,
more complex Cr-specific analyses that are
being developed will be done only for the
cross-link-positive groups or individuals.
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